Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

111 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25,735,284 shares of 45,101,565 outstanding shares and own 57.06% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,271,382 shares), BlackRock Inc. (2,767,360 shares), Sofinnova Investments, Inc. (2,194,278 shares), ALLIANCEBERNSTEIN L.P. (1,942,334 shares), VANGUARD GROUP INC (1,817,074 shares), Artisan Partners Limited Partnership (1,581,845 shares), FMR LLC (1,525,787 shares), STATE STREET CORP (1,456,670 shares), Polar Capital Holdings Plc (1,377,671 shares), and GEODE CAPITAL MANAGEMENT, LLC (620,977 shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.